Inspira Technologies OXY B.H.N. Ltd

Inspira Technologies Oxy B.H.N. Ltd. is a specialty medical device company focused on acute respiratory failure treatment. The company develops and manufactures proprietary life support technologies, with its primary product being the INSPIRA ART100, a cardiopulmonary bypass system designed for procedures lasting six hours or less. The device addresses a specific clinical need in acute respiratory support within hospital settings.

The company operates from its headquarters in Ra'anana, Israel, with a small operational footprint of 38 full-time employees. Inspira Technologies was incorporated in Israel in 2018, originally under the name Insense Medical Ltd. before rebranding to its current name in July 2020. Its market presence is currently concentrated in Israel, though the company is listed on Nasdaq, indicating access to broader capital markets.

The company's business model centers on the development and commercialization of its proprietary respiratory support technology. Revenue generation stems from sales of the INSPIRA ART100 system for use in acute care settings where temporary cardiopulmonary support is required.